INHIBITION OF RADIOGRAPHIC PROGRESSION AND ITS ASSOCIATION WITH CLINICAL PARAMETERS IN RA PATIENTS TREATED WITH CT-P13 AND INNOVATOR INFLIXIMAB IN PLANETRA STUDY - Forschungsportal der Justus-Liebig-Universität Gießen:

Meeting Abstract

INHIBITION OF RADIOGRAPHIC PROGRESSION AND ITS ASSOCIATION WITH CLINICAL PARAMETERS IN RA PATIENTS TREATED WITH CT-P13 AND INNOVATOR INFLIXIMAB IN PLANETRA STUDY

Autorenliste: Yoo, D.; Park, W.; Miranda, P.; Piotrowski, M.; Ramiterre, E.; Shevchuk, S.; Baranauskaite, A.; Lee, S.; Mueller-Ladner, U.

Jahr der Veröffentlichung: 2014

Seiten: 234-235

Zeitschrift: Annals of the Rheumatic Diseases

Bandnummer: 73

ISSN: 0003-4967

eISSN: 1468-2060

DOI Link: https://doi.org/10.1136/annrheumdis-2014-eular.3056

Konferenz: 15th Annual European Congress of Rheumatology (EULAR)

Verlag: Elsevier

Zitierstile

Harvard-Zitierstil: Yoo, D., Park, W., Miranda, P., Piotrowski, M., Ramiterre, E., Shevchuk, S., et al. (2014) INHIBITION OF RADIOGRAPHIC PROGRESSION AND ITS ASSOCIATION WITH CLINICAL PARAMETERS IN RA PATIENTS TREATED WITH CT-P13 AND INNOVATOR INFLIXIMAB IN PLANETRA STUDY, Annals of the Rheumatic Diseases, 73, pp. 234-235. https://doi.org/10.1136/annrheumdis-2014-eular.3056

APA-Zitierstil: Yoo, D., Park, W., Miranda, P., Piotrowski, M., Ramiterre, E., Shevchuk, S., Baranauskaite, A., Lee, S., & Mueller-Ladner, U. (2014). INHIBITION OF RADIOGRAPHIC PROGRESSION AND ITS ASSOCIATION WITH CLINICAL PARAMETERS IN RA PATIENTS TREATED WITH CT-P13 AND INNOVATOR INFLIXIMAB IN PLANETRA STUDY. Annals of the Rheumatic Diseases. 73, 234-235. https://doi.org/10.1136/annrheumdis-2014-eular.3056

Nachhaltigkeitsbezüge